| Trial ID: | L5161 |
| Source ID: | NCT03297879
|
| Associated Drug: |
Exenatide Or Metformin Hydrochloride
|
| Title: |
Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type2 Diabetes
|
| Interventions: |
DRUG: Exenatide or metformin hydrochloride
|
| Outcome Measures: |
Primary: The change of HbA1c, baseline and 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Beijing Chao Yang Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
230
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-01-01
|
| Completion Date: |
2016-02-28
|
| Results First Posted: |
|
| Last Update Posted: |
2017-10-02
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03297879
|
